Conditions: Gastrointestinal Stromal Tumors
Keywords: GIST Imatinib Sunitinib Gastrointestinal Stromal Tumors
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 125
Healthy volunteers: no

Brief summary:
This study will evaluate the preliminary efficacy of nilotinib in pretreated patients (Imatinib, Sunitinib) with unresectable or metastatic gastrointestinal stromal tumors.

Detailed description:

Arms:
arm 1: nilotinib 400 mg twice daily (bid).

Interventions: intervention 1: Nilotinib
Intervention descriptions: intervention 1: None

Protocol document: